U.S. Markets open in 2 hrs 54 mins

SHAREHOLDER ALERT: ABMD NTAP EVH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / August 26, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Abiomed, Inc. (ABMD)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/abiomed-inc-loss-submission-form?prid=3184&wire=1
Lead Plaintiff Deadline: October 7, 2019
Class Period: January 31, 2019 to July 31, 2019

Allegations against ABMD include that: (i) Abiomed’s revenue growth was in decline; (ii) the Company did not have a sufficient plan in place to stem its declining revenue growth; (iii) the Company was unlikely to restore its revenue growth over the next several fiscal quarters; (iv) consequently, Abiomed was reasonably likely to revise its full-year 2020 guidance in a way that would fall short of the Company’s prior projections and market expectations; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

NetApp, Inc. (NTAP)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/netapp-inc-loss-submission-form?prid=3184&wire=1
Lead Plaintiff Deadline: October 15, 2019
Class Period: May 22, 2019 to August 1, 2019

Allegations against NTAP include that: (1) the Company was unable to close large deals within the quarter and that the deals were pushed out to subsequent quarters or downsized; (2) as a result, the Company’s revenue would be materially impacted; (3) as a result, the Company would lower its fiscal 2020 guidance; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Evolent Health, Inc. (EVH)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/evolent-health-inc-loss-submission-form?prid=3184&wire=1
Lead Plaintiff Deadline: October 7, 2019
Class Period: March 3, 2017 to May 28, 2019

Allegations against EVH include that: (1) Evolent's partnership model was not aligned with its partners, as it was designed to parasitically increase its own revenue by extracting enormous administrative and management fees at the expense of its partners such as Passport Health Plan ("Passport"); (2) Passport was struggling financially, particularly after Kentucky cut its reimbursement rates, and the partnership between Evolent and Passport was becoming increasingly unsustainable; (3) Evolent was draining Passport of functions, employees, and money to such an extent that Passport was left on the verge of insolvency; (4) for several months, Passport was conducting a bidding process to sell itself to a financial buyer to prevent liquidation; and (5) as a result of the foregoing, Defendants public statements were materially false and/or misleading and/or lacked a reasonable basis.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong



View source version on accesswire.com:
https://www.accesswire.com/557507/SHAREHOLDER-ALERT-ABMD-NTAP-EVH-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines